Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cells

Oncogene

Volumn 32, Issue 50, 2013, Pages 5602-5613

  Lu, C ^a   Li, J Y ^a   Ge, Z ^a   Zhang, L ^a   Zhou, G P ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; CCAR1; leukemia; Notch3; Par 4; THAP1

Indexed keywords

CELL CYCLE AND APOPTOSIS REGULATOR 1 PROTEIN; MESSENGER RNA PRECURSOR; NOTCH3 RECEPTOR; PROTEIN; PROTEINASE ACTIVATED RECEPTOR 4; THAP 1 PROTEIN; UNCLASSIFIED DRUG; ZINC;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; T LYMPHOCYTE;

EID: 84890567244     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.349     Document Type: Article

References (25)

1. Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 2012; 366: 1371-1381.
2. Lu C, Chen JQ, Zhou GP, Wu SH, Guan YF, Yuan CS. Multimolecular complex of Par- 4 and E2F1 binding to Smac promoter contributes to glutamate-induced apoptosis in human bone mesenchymal stem cells. Nucleic Acids Res 2008; 36: 5021-5032.
3. Hebbar N, Wang C, Rangnekar VM. Mechanisms of apoptosis by the tumor suppressor Par-4. J Cell Physiol 2012; 227: 3715-3721.
4. Glienke W, Chow KU, Bauer N, Bergmann L. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Leuk Lymphoma 2006; 47: 1629-1638.
5. Ou CY, Kim JH, Yang CK, Stallcup MR. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage- independent growth of human colon carcinoma cells. J Biol Chem 2009; 284: 20629-20637.
6. Zhang L, Levi E, Majumder P, Yu Y, Aboukameel A, Du J. Transactivator of transcription- tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo. Mol Cancer Ther 2007; 6: 1661-1672.
7. Kent S, Hutchinson J, Balboni A, Decastro A, Cherukuri P, Direnzo J. DNp63a promotes cellular quiescence via induction and activation of Notch3. Cell Cycle 2011; 10: 3111-3118.
8. Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398-3406.
9. Campagne S, Saurel O, Gervais V, Milon A. Structural determinants of specific DNA-recognition by the THAP zinc finger. Nucleic Acids Res 2010; 38: 3466-3476.
10. Cayrol C, Lacroix C, Mathe C, Ecochard V, Ceribelli M, Loreau E. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood 2007; 109: 584-594.
11. Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem 2003; 278: 19995-20005.
12. Clouaire T, Roussigne M, Ecochard V, Mathe C, Amalric F, Girard JP. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc Natl Acad Sci USA 2005; 102: 6907-6912.
13. Tzoneva G, Ferrando AA. Recent advances on NOTCH signaling in T-ALL. Curr Top Microbiol Immunol 2012; 360: 163-182.
14. Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell 2008; 31: 510-519.
15. Aravind L, Koonin EV. SAP - a putative DNA-binding motif involved in chromosomal organization. Trends Biochem Sci 2000; 25: 112-114.
16. Park JT, IeM Shih, Wang TL. Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer. Cancer Res 2008; 68: 8852-8860.
17. Bellavia D, Mecarozzi M, Campese AF, Grazioli P, Talora C, Frati L. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J 2007; 26: 1670-1680.
18. Ling X, Yang J, Tan D, Ramnath N, Younis T, Bundy BN. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer 2005; 49: 353-361.
19. Yan XB, Tang CH, Huang Y, Fang H, Yu ZQ, Wu LM. Alternative splicing in exon 9 of glucocorticoid receptor pre-mRNA is regulated by SRp40. Mol Biol Rep 2010; 37: 1427-1433.
20. Boehrer S, Nowak D, Puccetti E, Ruthardt M, Sattler N, Trepohl B et al. Prostateapoptosis- response-gene-4 increases sensitivity to TRAIL-induced apoptosis. Leuk Res 2006; 30: 597-605.
21. Chow KU, Nowak D, Hofmann W, Schneider B, Hofmann WK. Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4. Leukemia 2005; 19: 1103-1105.
22. Wei B, Feng N, Zhou F, Lu C, Su J, Hua L. Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells. J Biomed Res 2010; 24: 58-63.
23. McFie PJ, Wang GL, Timchenko NA, Wilson HL, Hu X, Roesler WJ. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha. J Biol Chem 2006; 281: 18069-18080.
24. Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard JP. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 2003; 22: 2432-2442.
25. Zhang D, Jiang P, Xu Q, Zhang X. Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. J Biol Chem 2011; 286: 17746-17754.